|
|
|
|
|
Legal status
Patent in force
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| A61K 39/395 | (2006.01) | ||
| A61P 35/00 | (2006.01) | ||
| A61P 5/08 | (2006.01) |
| (11) | Number of the document | 2510002 |
| (13) | Kind of document | T |
| (96) | European patent application number | 10776753.5 |
| Date of filing the European patent application | 2010-11-18 | |
| (97) | Date of publication of the European application | 2012-10-17 |
| (45) | Date of publication and mention of the grant of the patent | 2016-08-24 |
| (46) | Date of publication of the claims translation | 2016-11-25 |
| (86) | Number | PCT/EP2010/067747 |
| Date | 2010-11-18 |
| (87) | Number | WO 2011/069799 |
| Date | 2011-06-16 |
| (30) | Number | Date | Country code |
| 09075546 | 2009-12-10 | EP |
| (72) |
OTTO, Christiane, DE
WOLF, Siegmund, DE
FREIBERG, Christoph, DE
HARRENGA, Axel, DE
GREVEN, Simone, DE
TRAUTWEIN, Mark, DE
BRUDER, Sandra, DE
EICKER, Andrea, DE
WILMEN, Andreas, DE
|
| (73) |
Bayer Intellectual Property GmbH ,
Alfred-Nobel Strasse 50, 40789 Monheim an Rhein,
DE
|
| (74) |
Liudmila GERASIMOVIČ,
IĮ "Liudmila Gerasimovič, Patentinis patikėtinis", Vingrių g. 13-42, LT-01141 Vilnius,
LT
|
| (54) | Antikūnai, neutralizuojantys prolaktino receptorių, ir jų terapinis panaudojimas |
| NEUTRALIZING PROLACTIN RECEPTOR ANTIBODIES AND THEIR THERAPEUTIC USE |
| Payment date | Validity (years) | Amount | |
| 2025-10-21 | 16 | 347.00 EUR |
| 2026-11-18 |